标题
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-05-10
DOI
10.1038/s41598-017-02068-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
- (2016) Huixin Hao et al. Oncotarget
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability
- (2014) Neerupma Silswal et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
- (2014) G. S. Di Marco et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy
- (2013) Chad D. Touchberry et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults
- (2013) Anna Jovanovich et al. ATHEROSCLEROSIS
- Evolving importance of kidney disease: from subspecialty to global health burden
- (2013) Kai-Uwe Eckardt et al. LANCET
- Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy
- (2013) Sarah N. Cilvik et al. PLoS One
- Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, Soft Tissue Mineralization, and Cardiovascular Dysfunction
- (2013) Gina M. Yanochko et al. TOXICOLOGICAL SCIENCES
- Cardiorenal Syndrome Type 4: A Review
- (2013) Anna Clementi et al. CardioRenal Medicine
- Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease
- (2012) Dao-Fu Dai et al. ANTIOXIDANTS & REDOX SIGNALING
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- Fibroblast Growth Factor 23, Cardiovascular Disease Risk Factors, and Phosphorus Intake in the Health Professionals Follow-up Study
- (2011) O. M. Gutierrez et al. Clinical Journal of the American Society of Nephrology
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Cardioprotective effect of calcineurin inhibition in an animal model of renal disease
- (2010) Giovana S. Di Marco et al. EUROPEAN HEART JOURNAL
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Erythropoietin Therapy and Left Ventricular Mass Index in CKD and ESRD Patients: A Meta-Analysis
- (2009) P. S. Parfrey et al. Clinical Journal of the American Society of Nephrology
- The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis
- (2009) M. Shawkat Razzaque Nature Reviews Endocrinology
- FGFR3 and FGFR4 Do not Mediate Renal Effects of FGF23
- (2008) S. Liu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started